Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI) (MOBILE)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Sponsor: Zimmer Biomet
Terminated
Primary endpoint not met, remaining long-term follow-up not needed.
This NA trial investigates Critical Limb Ischemia and Peripheral Arterial Disease and is currently terminated or withdrawn. Zimmer Biomet leads this study, which shows 12 recorded versions since 2010 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jun 2021 — Jul 2024 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
Jan 2021 — Jun 2021 [monthly]
Active Not Recruiting NA
-
May 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
▶ Show 7 earlier versions
-
Aug 2019 — May 2020 [monthly]
Active Not Recruiting NA
-
Jul 2018 — Aug 2019 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting NA
-
Aug 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
-
Apr 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
-
Feb 2017 — Apr 2017 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Jun 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Zimmer Biomet
For direct contact, visit the study record on ClinicalTrials.gov .